Prognostic importance of plasma lipoprotein-analyses in patients with unstable coronary artery disease

References

• Steinberg D, Witzum J L. Lipoproteins and athero-genesis. JAMA 1990; 264(23)3047–52
   PubMed Web of Science ®Google Scholar
• Feldman R L. Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction. Am J Card 1987; 59: 1187–90
   PubMed Web of Science ®Google Scholar
• Goodnight S H, Harris W S, Connor W E, Illing-Worth D R. Polyunsaturated fatty acids, hyper-lipidemia, and thrombosis. Arteriosclerosis 1982; 2: 87–113
   PubMedGoogle Scholar
• Mbewu A D, Durrington P N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Rose G A, Blackburn G. Geneva 1968. Cardiovascular survey methods, G A Rose, H. Blackburn. WHO, Geneva 1968
   Google Scholar
• Gillman R F, Forkman S P, Prineas R J, Kottke T E. International diagnostic criteria for acute myocardial infarction and stroke. Progress in cardiology 1984; 108: 150–7
   Google Scholar
• Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease - safety and diagnostic value. Eur Heart J 1986; 7: 594–601
   PubMed Web of Science ®Google Scholar
• Gore J, Goldberg R, Matsumoto A, Castelli W, McNamara P, Dalen J. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984; 54: 722–25
   PubMed Web of Science ®Google Scholar
• Laurell C-B. Electroimmunosasay. SJCLI, 29(Suppl 124)21–37
   Google Scholar
• Swahn E, Areskog M, Wallentin L. Predictive importance of clinical findings and a predischarge exercise test in suspected unstable coronary artery disease. Am J cardiol 1987; 59: 208–14
   PubMed Web of Science ®Google Scholar
• Reardon M F, Nestel P J, Craig I H, Harper R W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985; 881–8
   PubMed Web of Science ®Google Scholar
• Kladetzky R G, Assmann G, Walgenback S, Tauchet P, Helb H D. Lipoprotein and apoprotein values in coronary angiography patients. Artery 1980; 7: 191
   PubMedGoogle Scholar
• Kwiterovich P, Coresh J, Smith H, Bachorik P, Derby C, Pearson T. Comparison of the plasma levels of apolipoproteins B and Al, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 1992; 69: 1015–21
   PubMed Web of Science ®Google Scholar
• Genest J, McNamara J, Ordovas J, Jenner J, Wilberman S, Anderson K, Wilson P, Salem D, Schaefer E. J Am Coll Cardiol 1992; 19: 792–802
   PubMed Web of Science ®Google Scholar
• Stokes J, Kannel W B, Wolf P A, Cupples L A, D'Agostino R B. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35–64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987; 75(suppl V)V65–73
   PubMed Web of Science ®Google Scholar
• Croft P, Hannaford P. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ 1989; 298: 165–8
   PubMed Web of Science ®Google Scholar
• Castelli W P. The triglyceride issue: A view from Framingham. Am Heart J 1986; 112: 432–7
   PubMed Web of Science ®Google Scholar
• Carlson L A, Bottiger L E. Risk factors for ischae-mic heart disease in men and women. Acta Med Scand 1985; 218: 207–11
   PubMed Web of Science ®Google Scholar
• Carlson L A, Bottiger L E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm Prospective Study. Lancet 1972; 1: 865–8
   PubMed Web of Science ®Google Scholar
• Lapidus L, Bengtsson C, Lindquist O, Sigurdsson J A, Rybo E. Triglycerides-Main lipid risk factor for cardiovascular disease in women. Acta Med Scand 1985; 217: 481–9
   PubMed Web of Science ®Google Scholar
• Greenhalgh R, Rosengren D, Mervart I, Lewis B, Calnan J, Martin P. Serum lipids and lipoproteins in peripheral vascular disease. Lancet 1971; 30: 947–50
   Google Scholar
• Dahlen G H, Guyton J R, Attar M, Farmer J A, Kautz J, Gotta A M. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
   PubMed Web of Science ®Google Scholar
• Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer K H, Kostner G M. Lipoprotein Lp(a), a risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 398–401
   PubMedGoogle Scholar
• Hoff H F, Beck G J, Skibinski C I, Jiirgens G, O'Neil J, Kramer J, Lytle B. Serum Lp level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1238–44
   PubMed Web of Science ®Google Scholar
• Ambrose J A, Winters S L, Stern A, Eng A, Teichholz L E, Gorlin R, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609–16
   PubMed Web of Science ®Google Scholar
• Davies M J, Thomas A C, Knapman P A, Hangartner J R. Intramyocardial platelet aggregation in patients with unstable angina pectoris suffering sudden ischemic cardiac death. Circulation 1986; 73: 418–27
   PubMed Web of Science ®Google Scholar
• Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71: 699–708
   PubMed Web of Science ®Google Scholar
• Maseri A, Chierchi S, L'Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62(suppl V)3–13
   Google Scholar
• Houlston R, Friedl W. Biochemistry and clinical significance of lipoprotein (a). Ann Clin Biochem 1988; 25: 499–503
   PubMed Web of Science ®Google Scholar